Private Label Brightening Body Milk Low MOQ Supplier

Is tranexamic acid safe and legal in cosmetic body products in the US and EU?

By Blake Mereby · Last reviewed October 5, 2026

Tranexamic acid (TXA) is a synthetic amino acid derivative with a well-documented safety profile in pharmaceutical applications. At topical cosmetic concentrations — typically 1 to 3% — it is considered safe for use in leave-on skin care, including body milks, based on published clinical data and dermatologist review. The FDA does not currently restrict TXA as a cosmetic ingredient in the United States, and it appears in numerous commercially available brightening products across mass, masstige, and prestige channels without restriction.

The critical regulatory issue in the US is not the ingredient itself but the claims you make on the label and in marketing. If you describe the product as treating melasma, reversing hyperpigmentation, or otherwise altering skin biology in a way that implies drug action, the FDA can classify your product as an OTC drug. Drug products require either a New Drug Application or compliance with a monograph — neither of which TXA currently has an established path for in the US OTC drug context. Stick to cosmetic structure-function language: 'visibly brightens', 'promotes an even-looking complexion', 'skin appears more luminous'. Have these claims reviewed by a regulatory affairs consultant before you go to print.

In the European Union, tranexamic acid is not currently listed as a restricted or prohibited ingredient in the Cosmetics Regulation (EC) No 1223/2009. However, the EU requires a Cosmetic Product Safety Report (CPSR) signed by a qualified safety assessor before any product can be placed on the EU market. This CPSR must assess TXA at your specific use concentration. Your manufacturer can sometimes arrange CPSR services, or you can engage an independent EU regulatory consultant — costs typically run €600 to €1,800 per formula.

Kojic acid has a more complex EU history. The EU Scientific Committee on Consumer Safety (SCCS) has issued opinions on kojic acid at various concentrations, and it has faced temporary restrictions in face products above 1%. At the time of writing, kojic acid is permitted in face products up to 1% and in body products up to certain concentrations, but regulations do change — always verify current Annex II, III, and V listings with an EU-qualified regulatory consultant before finalising your formula for European distribution.

For the UK post-Brexit, the Great Britain cosmetics regulation broadly mirrors the EU framework but is administered by the OPSS under UK REACH and the Cosmetic Products (Safety) Regulations 2004 as amended. Notify via the UK Cosmetic Product Notification Portal (CPNP equivalent) before placing product on the GB market.

In markets like South Korea, Japan, and several Southeast Asian countries, both TXA and kojic acid are widely used and often more permissively regulated, with established safety dossiers. If you're targeting these markets, work with a local regulatory agent to navigate MFDS (Korea), PMDA (Japan), or ASEAN Cosmetic Directive requirements.

Always instruct your cosmetic chemist or the manufacturer's in-house formulator to provide a full safety justification document alongside the INCI list. AJ Cosmo Labs manufacturers listed on the platform are asked to confirm GMP compliance and safety assessment practices as part of the onboarding process.

Ingredients in this answer: Tranexamic Acid · Kojic Acid

Read the full guide on Private Label Brightening Body Milk Low MOQ Supplier →

More about Private Label Brightening Body Milk Low MOQ Supplier

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app